TY - JOUR AU - Scott, Jane Anne AU - Burns, Sharyn K AU - Hauck, Yvonne L AU - Giglia, Roslyn C AU - Jorgensen, Anita M AU - White, Becky Kate AU - Martin, Annegret AU - Robinson, Suzanne AU - Dhaliwal, Satvinder S AU - Binns, Colin W AU - Maycock, Bruce R PY - 2021 DA - 201/4/12 TI -针对父亲的面对面与智能手机应用程序与联合母乳喂养干预的影响:随机对照试验JO - JMIR儿科父母SP - e24579 VL - 4 IS - 2 KW -母乳喂养KW -父亲KW -同伴支持KW - mHealth，智能手机应用KW -婴儿KW -社会支持KW -喂养KW -智能手机AB -背景:尽管公认的纯母乳喂养的健康和经济效益，很少有澳大利亚婴儿在5个月以上纯母乳喂养。社会对母乳喂养的支持，特别是婴儿父亲的支持，被认为是成功母乳喂养的关键因素。目的:本研究的目的是确定各种以父亲为中心的母乳喂养干预措施在关键婴儿喂养结果方面的有效性。方法:该研究是一项在澳大利亚珀斯进行的四组、阶乘、随机对照试验。试验组包括一个对照组和3项干预措施，包括由一名男性同伴辅导员主持的以父亲为中心的面对面产前母乳喂养课程;专门为父亲设计的哺乳智能手机应用Milk Man;两种干预措施的结合。从医院的产前班招募准夫妇，并随机分组到4组中的1组。每个伴侣都在招募时、产后6周和26周完成了调查。 Primary outcomes were duration of exclusive and any breastfeeding. Secondary outcomes included age of introduction of formula and complementary foods, maternal breastfeeding self-efficacy, and partner postpartum support. Results: A total of 1426 couples were recruited from public (443/1426, 31.1%) and private (983/1426, 68.9%) hospitals. Of these, 76.6% (1092/1426) of fathers completed the baseline questionnaire, 58.6% (836/1426) completed the 6-week follow-up questionnaire, and 49.2% (702/1426) completed the 26-week follow-up questionnaire. The average age of fathers who completed the baseline questionnaire was 33.6 (SD 5.2) years; the majority were born in Australia (76.4%) and had attended university (61.8%). There were no significant differences between the control and any of the intervention groups in any of the infant feeding outcomes or level of breastfeeding self-efficacy and postpartum partner support reported by mothers. Conclusions: This study did not demonstrate that any intervention was superior to another or that any intervention was inferior to the standard care delivered in routine antenatal classes. Further studies are needed to test the effectiveness of these interventions in more socioeconomically diverse populations that are likely to benefit most from additional partner supports. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12614000605695; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12614000605695 International Registered Report Identifier (IRRID): RR2-10.1186/s12884-015-0601-5 SN - 2561-6722 UR - https://pediatrics.www.mybigtv.com/2021/2/e24579 UR - https://doi.org/10.2196/24579 UR - http://www.ncbi.nlm.nih.gov/pubmed/33843604 DO - 10.2196/24579 ID - info:doi/10.2196/24579 ER -